Search

everythinglearnresearchcommunity

for

Search:↓

Some individuals experience side effects from 5AR inhibitors like finasteride and are considering hair transplants without these medications, with some opting for surgeons like Dr. Zarev. Others are exploring alternative treatments and waiting for new medications in development, while some discuss managing side effects through lifestyle changes or additional medications.

The conversation discusses hair loss treatments, including oral finasteride, topical minoxidil, and microneedling, and the potential impact of Vitamin D and folic acid deficiencies on hair regrowth. It suggests that while male pattern baldness is the primary cause, addressing vitamin deficiencies may aid in improving regrowth.

The conversation discusses hair loss causes beyond male pattern baldness, mentioning treatments like ketoconazole, zinc shampoo, and finasteride. Stress-related hair loss (telogen effluvium) is also suggested.

A 26-year-old man from France started experiencing hair loss in September 2020 and began using finasteride in June 2021, reporting some improvement after three months without side effects. He plans to continue finasteride for a year before considering additional treatments like minoxidil or dermarolling.

A young man faces severe hair loss in his early 20s, using treatments like dutasteride and minoxidil with little success, impacting his self-esteem and relationships. He considers hair systems and therapy as potential solutions.

The user experienced hair regrowth and stabilization at Norwood 2 using natural remedies like pumpkin seed oil, rosemary oil, vitamins, and scalp massages, avoiding minoxidil and finasteride due to side effects. Another user suggested starting topical finasteride earlier to prevent further hair loss.

A 31-year-old man using finasteride for a year is considering adding oral minoxidil or switching to topical minoxidil to address diffuse thinning, while also using a scalp massager and ketoconazole shampoo. Concerns include cardiovascular side effects, pet safety with topical minoxidil, and cost of telehealth services.

The user's hairline is receding despite using finasteride for 7-8 years and minoxidil for 1 year, with inconsistent usage. They are considering other treatments like microneedling.

Some embrace baldness, while others promote treatments like minoxidil and finasteride. Opinions differ on accepting baldness versus pursuing hair regrowth.

The conversation humorously discusses an extensive and exaggerated hair loss treatment regimen, including finasteride, dutasteride, minoxidil, pyrilutamide, RU58841, and various other therapies. Despite the numerous treatments, the effectiveness is questioned, and the user humorously considers adding more minoxidil.

Alfatradiol is considered safe but less effective than finasteride for hair loss. One user reported subtle regrowth using alfatradiol with finasteride and minoxidil, while another found alfatradiol ineffective.

The user started oral minoxidil and finasteride two months after a hair transplant and plans to switch to dutasteride, using Nizoral and Mossi shampoos. They are considering a second transplant in Tijuana and using hair fibers and mousse for styling while waiting for medication effects.

The conversation is about hair loss and treatments, with suggestions to use finasteride or dutasteride as DHT blockers and minoxidil for regrowth. Oils and shampoos are considered ineffective for androgenic alopecia without these medications.

The user is experiencing hair loss, possibly due to androgenetic alopecia and seborrheic dermatitis, and has tried ketoconazole shampoo without success. They are hesitant to use finasteride due to potential side effects and are seeking advice on managing their condition.

The conversation is about hair regrowth, with the original poster using natural oils and supplements like pumpkin seed, saw palmetto, and zinc, while considering pharmaceutical options like minoxidil, finasteride, and dutasteride. Most users suggest using finasteride or dutasteride for effective results, as natural remedies are seen as ineffective.

The user shared a 6-month update on their hair loss treatment, using finasteride/minoxidil gel, ketoconazole shampoo, thickening shampoo and conditioner, and topical minoxidil. They wash their hair three times a week and switched to a less oily topical foam. Other users commented on their hairstyle, advising against it to prevent traction alopecia.

The conversation discusses alternatives to minoxidil and finasteride for hair regrowth, with mentions of essential oils, PRP therapy, and RU58841. The focus is on finding treatments with minimal side effects, especially concerning fertility.

A 21-year-old is experiencing hair thinning and is using oral finasteride and topical minoxidil, considering adding oral minoxidil. They are unsure if the condition is androgenetic alopecia (AGA) or telogen effluvium (TE) and are advised to continue treatments and get a blood test.

Hair loss treatment using 1.25 Finasteride Teva daily, Folcare Minoxidil 5% 2x a day, dermarolling, Nizoral, Hask biotin boost shampoo, and 5000mg biotin pill. User unsure if experiencing regrowth or just growth, especially in crown area.

Topical treatments like minoxidil and finasteride are preferred for hair loss due to ease of use and natural appearance. Hair systems are considered high-maintenance and less genuine.

A user experienced significant hair regrowth after 5 weeks by taking zinc, vitamin D, and biotin supplements, correcting deficiencies that were contributing to hair loss and thinning. They report a decrease in hair shedding, faster hair growth, and a thickening of their hairline without using common hair loss medications like Minoxidil or Finasteride.

A 28-year-old male is experiencing rapid hair loss and is considering using Minoxidil and finasteride to restore his hairline but is concerned about potential side effects. He prefers not to undergo a hair transplant due to cost and seeks advice on maintaining attractiveness.

A rigorous and extensive regimen for hair regrowth, including oral and topical minoxidil, finasteride, dutasteride, RU58841, various oils, supplements, and lifestyle changes, is discussed with skepticism and humor. The consensus is that such an extreme routine is impractical and potentially harmful, with no guaranteed results.

A user shared their experience with hair loss and a hair transplant at the Scandinavian Hair Institute, using finasteride every other day as part of their regimen. They expressed satisfaction with the transplant results and decided against using minoxidil due to its inconvenience and potential side effects.

The user showed hair regrowth after two years using finasteride, minoxidil, micro needling, and ketoconazole shampoo, noticing significant improvement around 8-10 months without experiencing shedding. They achieved thicker hair and improved temples, allowing them to style their hair without wearing hats.

PP-405, a potential hair loss treatment, shows promise in stimulating dormant hair follicles and may help with various hair loss types. Current treatments like Minoxidil are still recommended as PP-405 is in early trials and may take years to become available.

The user is using Minoxidil, finasteride, Nizoral, and dermarolling for hair loss but is not seeing results. They are considering trying a product called "capilia longa" for beard growth and are questioning its effectiveness.

Hair loss treatments, specifically finasteride and minoxidil, being used by wealthy individuals to combat their genetic predisposition to baldness. It also discussed other potential treatments such as RU58841 and dutasteride.

A 35-year-old male shared his hair restoration journey, starting with minoxidil and finasteride, which improved his hairline and crown, followed by a hair transplant in November 2024. He stopped finasteride to conceive, experienced some shedding, and is now considering switching to dutasteride while continuing minoxidil.

HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.